AU2003291402A1 - MIP-1Alpha AND GM-CSF AS ADJUVANTS OF IMMUNE RESPONSE - Google Patents
MIP-1Alpha AND GM-CSF AS ADJUVANTS OF IMMUNE RESPONSEInfo
- Publication number
- AU2003291402A1 AU2003291402A1 AU2003291402A AU2003291402A AU2003291402A1 AU 2003291402 A1 AU2003291402 A1 AU 2003291402A1 AU 2003291402 A AU2003291402 A AU 2003291402A AU 2003291402 A AU2003291402 A AU 2003291402A AU 2003291402 A1 AU2003291402 A1 AU 2003291402A1
- Authority
- AU
- Australia
- Prior art keywords
- 1alpha
- mip
- csf
- adjuvants
- immune response
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 title 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 title 1
- 239000002671 adjuvant Substances 0.000 title 1
- 230000028993 immune response Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42465802P | 2002-11-07 | 2002-11-07 | |
| US60/424,658 | 2002-11-07 | ||
| PCT/US2003/035693 WO2004044155A2 (en) | 2002-11-07 | 2003-11-07 | MIP-1α AND GM-CSF AS ADJUVANTS OF IMMUNE RESPONSE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003291402A1 true AU2003291402A1 (en) | 2004-06-03 |
| AU2003291402A8 AU2003291402A8 (en) | 2004-06-03 |
Family
ID=32312848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003291402A Abandoned AU2003291402A1 (en) | 2002-11-07 | 2003-11-07 | MIP-1Alpha AND GM-CSF AS ADJUVANTS OF IMMUNE RESPONSE |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003291402A1 (en) |
| WO (1) | WO2004044155A2 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101119743B (en) * | 2005-01-31 | 2012-09-26 | 株式会社Eci | Immunopotentiating agent |
| WO2009024426A1 (en) * | 2007-07-27 | 2009-02-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Immunizing compositions for inducing 'bystander' killing of pathogens |
| SMT202000101T1 (en) | 2008-10-10 | 2020-03-13 | Childrens Medical Center | Biochemically stabilized hiv-1 env trimer vaccine |
| WO2012023631A1 (en) * | 2010-08-19 | 2012-02-23 | 株式会社Eci | Pharmaceutical composition for inhibiting proliferation of cancer cells which comprises heat shock protein (hsp) and eci301 polypeptide, and cancer treatment method using same |
| EA030983B1 (en) | 2013-01-07 | 2018-10-31 | Бет Изрейэл Диконисс Медикал Сентер, Инк. | STABILIZED HUMAN IMMUNODEFICIENCY VIRUS (HIV) ENVELOPE (Env) TRIMER VACCINES AND METHODS OF USING THE SAME |
| EP3052132B1 (en) | 2013-09-30 | 2020-07-29 | Beth Israel Deaconess Medical Center, Inc. | Antibody therapies for human immunodeficiency virus (hiv) |
| EP3052518B1 (en) | 2013-10-04 | 2020-01-08 | Beth Israel Deaconess Medical Center, Inc. | Stabilized human immunodeficiency virus (hiv) clade c envelope (env) trimer vaccines and methods of using same |
| PH12017500449B1 (en) | 2014-09-26 | 2022-07-22 | Beth Israel Deaconess Medical Ct Inc | Methods and compositions for inducing protective immunity against human immunodeficiency virus infection |
| CN108368157B (en) | 2015-12-15 | 2022-04-15 | 扬森疫苗与预防公司 | Human immunodeficiency virus antigens, vectors, compositions, and methods of use thereof |
| EA201892735A1 (en) | 2016-06-16 | 2019-05-31 | Янссен Вэксинс Энд Превеншн Б.В. | COMPOSITION OF VACCINE AGAINST HIV |
| AU2017318689A1 (en) | 2016-09-02 | 2019-04-11 | Beth Israel Deaconess Medical Center, Inc. | Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment |
| MA46230B1 (en) | 2016-09-15 | 2020-10-28 | Janssen Vaccines & Prevention Bv | HIV envelope protein mutations stabilizing the trimeric form |
| WO2018075559A1 (en) | 2016-10-17 | 2018-04-26 | Beth Israel Deaconess Medical Center, Inc. | Signature-based human immunodeficiency virus (hiv) envelope (env) trimer vaccines and methods of using the same |
| US11229693B2 (en) | 2017-06-15 | 2022-01-25 | Janssen Vaccines & Prevention B.V. | Poxvirus vectors encoding HIV antigens, and methods of use thereof |
| JP7253529B2 (en) | 2017-07-19 | 2023-04-06 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | Trimer-stabilizing HIV envelope protein mutations |
| EP3797118A4 (en) | 2018-05-22 | 2022-06-29 | Beth Israel Deaconess Medical Center, Inc. | Antibody therapies for human immunodeficiency virus (hiv) |
| EP3883962A4 (en) | 2018-11-21 | 2023-04-12 | Beth Israel Deaconess Medical Center, Inc. | ANTIBODY TREATMENTS FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV) |
| US20240197867A1 (en) * | 2021-02-26 | 2024-06-20 | The Feinstein Institutes For Medical Research | Neural control of adaptive immunity |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5935568A (en) * | 1995-05-18 | 1999-08-10 | National Jewish Medical & Research Center | Gene therapy for effector cell regulation |
-
2003
- 2003-11-07 AU AU2003291402A patent/AU2003291402A1/en not_active Abandoned
- 2003-11-07 WO PCT/US2003/035693 patent/WO2004044155A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004044155A8 (en) | 2004-08-19 |
| WO2004044155A2 (en) | 2004-05-27 |
| WO2004044155A3 (en) | 2005-10-06 |
| AU2003291402A8 (en) | 2004-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003291402A1 (en) | MIP-1Alpha AND GM-CSF AS ADJUVANTS OF IMMUNE RESPONSE | |
| AU2003258714A1 (en) | Immune modulatory compounds and methods | |
| WO2003072035A8 (en) | Compositions and methods for the treatment of immune related diseases | |
| WO2004041170A9 (en) | Compositions and methods for the treatment of immune related diseases | |
| WO2004024097A9 (en) | Compositions and methods for the treatment of immune related diseases | |
| AU2003259735A1 (en) | Small-mer compositions and methods of use | |
| ZA200602950B (en) | Vaccine compositions comprising an interleukin 18 and saponin adjuvant system | |
| AU2008243079A1 (en) | Compositions and methods for generating an immune response | |
| AU2002242085A1 (en) | Methods and compositions useful for stimulating an immune response | |
| WO2005025604A3 (en) | Use of hmgb and hmgb fragments to decrease specific immune response | |
| AU2003299823A1 (en) | Methods of inducing and maintaining immune tolerance | |
| AU2003217105A1 (en) | Novel of cytokine inhibitors | |
| AU2003270779A1 (en) | Vaccine compositions and adjuvant | |
| AU2003303926A1 (en) | Ceramics and methods of making the same | |
| AU2003259374A1 (en) | Vaccine comprising il-13 and an adjuvant | |
| WO2004024076A8 (en) | Novel compositions and methods for the treatment of immune related diseases | |
| AU2003245134A1 (en) | Oxytocin as cardiomyogenesis inducer and uses thereof | |
| AU2003302234A1 (en) | Immune response associated proteins | |
| AU2003260818A1 (en) | Treatment of immune system dysfunction | |
| AU2002361488A1 (en) | Field and background of the invention | |
| AU2003239773A1 (en) | Preparation of vaccines | |
| AU2003268230A1 (en) | Immune response associated proteins | |
| AU2003212475A1 (en) | Immune response associated proteins | |
| AU2002240013A1 (en) | Chemokines as adjuvants of immune response | |
| AU2003221470A1 (en) | Furniture connection system and furniture assembled by use of the connection system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |